Hawaii 2023 Regular Session

Hawaii Senate Bill SCR209 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	THE SENATE S.C.R. NO. 209 THIRTY-SECOND LEGISLATURE, 2023 STATE OF HAWAII SENATE CONCURRENT RESOLUTION requesting the Department of Health to conduct a social and financial assessment of proposed mandatory health insurance coverage for weight management medication.
2	2
3	3	THE SENATE S.C.R. NO. 209
4	4	THIRTY-SECOND LEGISLATURE, 2023
5	5	STATE OF HAWAII
6	6
7	7	THE SENATE
8	8
9	9	S.C.R. NO.
10	10
11	11	209
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2023
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29	SENATE CONCURRENT
30	30
31	31	RESOLUTION
32	32
33	33
34	34
35	35
36	36
37	37	requesting the Department of Health to conduct a social and financial assessment of proposed mandatory health insurance coverage for weight management medication.
38	38
39	39
40	40
41	41
42	42
43	43	WHEREAS, the National Institutes of Health has reported that obesity and being overweight are now the second leading cause of death nationally, with an estimated three hundred thousand deaths a year attributed to the epidemic; and WHEREAS, obesity increases the risk for chronic diseases and conditions, including high blood pressure, heart disease, certain cancers, arthritis, mental illness, lipid disorders, sleep apnea, and type 2 diabetes; and WHEREAS, clinicians increasingly recognize that obesity is closely linked to genetics and environmental factors; and WHEREAS, more than half of Medicare beneficiaries are treated for five or more chronic conditions per year; and WHEREAS, the rate of obesity among Medicare beneficiaries doubled from 1987 to 2002 and nearly doubled again by 2016, with Medicare spending on individuals with obesity during that time rising proportionately to reach $50 billion in 2014; and WHEREAS, on average, a Medicare beneficiary with obesity costs $2,018 more than a healthy-weight beneficiary; and WHEREAS, Senate Bill No. 1020, introduced in the Regular Session of 2023, proposes to expand existing health insurance mandates to cover weight management medication for persons who are obese or overweight with one or more related comorbidities; now, therefore, BE IT RESOLVED by the Senate of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2023, the House of Representatives concurring, that the Department of Health is requested to conduct an impact assessment report of mandating health insurance coverage for weight management medication as proposed in Senate Bill No. 1020, introduced in the Regular Session of 2023; and BE IT FURTHER RESOLVED that the Department of Health is further requested to include in its assessment the impact of section 1311(d)(3) of the federal Patient Protection and Affordable Care Act (PPACA) on Senate Bill No. 1020, or similar legislation that includes but is not limited to the additional cost of any benefits beyond the essential health benefits of Hawaii's qualified health plans under the PPACA; and BE IT FURTHER RESOLVED that the Department of Health is also requested to determine how many qualified health plans are available in Hawaii, including plans offered by health maintenance organizations; the individual or group enrollment in these plans; and the actuarial cost of the defrayment to the State for the reimbursement of weight management medication; and BE IT FURTHER RESOLVED that the Department of Health is requested to submit a report on its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2024; and BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to the Department of Health and Insurance Commissioner, who is requested to transmit copies to each insurer in the State that issues health insurance policies. OFFERED BY: _____________________________ Report Title: Department of Health; Social and Financial Impact Study; Insurance Coverage; Weight Management Medication
44	44
45	45	WHEREAS, the National Institutes of Health has reported that obesity and being overweight are now the second leading cause of death nationally, with an estimated three hundred thousand deaths a year attributed to the epidemic; and
46	46
47	47
48	48
49	49	WHEREAS, obesity increases the risk for chronic diseases and conditions, including high blood pressure, heart disease, certain cancers, arthritis, mental illness, lipid disorders, sleep apnea, and type 2 diabetes; and
50	50
51	51
52	52
53	53	WHEREAS, clinicians increasingly recognize that obesity is closely linked to genetics and environmental factors; and
54	54
55	55
56	56
57	57	WHEREAS, more than half of Medicare beneficiaries are treated for five or more chronic conditions per year; and
58	58
59	59
60	60
61	61	WHEREAS, the rate of obesity among Medicare beneficiaries doubled from 1987 to 2002 and nearly doubled again by 2016, with Medicare spending on individuals with obesity during that time rising proportionately to reach $50 billion in 2014; and
62	62
63	63
64	64
65	65	WHEREAS, on average, a Medicare beneficiary with obesity costs $2,018 more than a healthy-weight beneficiary; and
66	66
67	67
68	68
69	69	WHEREAS, Senate Bill No. 1020, introduced in the Regular Session of 2023, proposes to expand existing health insurance mandates to cover weight management medication for persons who are obese or overweight with one or more related comorbidities; now, therefore,
70	70
71	71
72	72
73	73	BE IT RESOLVED by the Senate of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2023, the House of Representatives concurring, that the Department of Health is requested to conduct an impact assessment report of mandating health insurance coverage for weight management medication as proposed in Senate Bill No. 1020, introduced in the Regular Session of 2023; and
74	74
75	75
76	76
77	77	BE IT FURTHER RESOLVED that the Department of Health is further requested to include in its assessment the impact of section 1311(d)(3) of the federal Patient Protection and Affordable Care Act (PPACA) on Senate Bill No. 1020, or similar legislation that includes but is not limited to the additional cost of any benefits beyond the essential health benefits of Hawaii's qualified health plans under the PPACA; and
78	78
79	79
80	80
81	81	BE IT FURTHER RESOLVED that the Department of Health is also requested to determine how many qualified health plans are available in Hawaii, including plans offered by health maintenance organizations; the individual or group enrollment in these plans; and the actuarial cost of the defrayment to the State for the reimbursement of weight management medication; and
82	82
83	83
84	84
85	85	BE IT FURTHER RESOLVED that the Department of Health is requested to submit a report on its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2024; and
86	86
87	87
88	88
89	89	BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to the Department of Health and Insurance Commissioner, who is requested to transmit copies to each insurer in the State that issues health insurance policies.
90	90
91	91
92	92
93	93
94	94
95	95
96	96
97	97	OFFERED BY: _____________________________
98	98
99	99
100	100
101	101	OFFERED BY:
102	102
103	103	_____________________________
104	104
105	105
106	106
107	107
108	108
109	109	Report Title:
110	110
111	111	Department of Health; Social and Financial Impact Study; Insurance Coverage; Weight Management Medication